Lisa M. M Minter

Prof. Lisa M. M Minter


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
HYHaixia Yang
Haixia Yang
WWWeicang Wang
Weicang Wang
KRKymberleigh A. Romano
Kymberleigh A. Romano
MGMin Gu
Min Gu
KSKatherine Z. Sanidad
Katherine Z. Sanidad
GZGuodong Zhang
Guodong Zhang
Triclosan (TCS) is a high-volume chemical used as an antimicrobial ingredient in more than 2000 consumer products, such as toothpaste, cosmetics, kitchenware, and toys. We report that brief exposure to TCS, at relatively low doses, causes low-grade colonic inflammation, increases colitis, and exacerbates colitis-associated colon cancer in mice. Exposure to TCS alters gut microbiota in mice, and its proinflammatory effect is attenuated in germ-free mice. In addition, TCS treatment increases activation of Toll-like receptor 4 (TLR4) signaling in vivo and fails to promote colitis in Tlr4−/− mice. Together, our results demonstrate that this widely used antimicrobial ingredient could have adverse effects on colonic inflammation and associated colon tumorigenesis through modulation of the gut microbiota and TLR4 signaling. Together, these results highlight the need to reassess the effects of TCS on human health and potentially update policies regulating the use of this widely used antimicrobial.

1 January 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ADAnushka Dongre
Anushka Dongre
LSLalitha Surampudi
Lalitha Surampudi
RLRebecca G. Lawlor
Rebecca G. Lawlor
AFAbdul H. Fauq
Abdul H. Fauq
LMLucio Miele
Lucio Miele
BOBarbara A. Osborne
Barbara A. Osborne
Cleavage of the Notch receptor via a γ-secretase, results in the release of the active intra-cellular domain of Notch that migrates to the nucleus and interacts with RBP-JΚ, resulting in the activation of downstream target genes. This canonical Notch signaling pathway has been documented to influence T-cell development and function. However, the mechanistic details underlying this process remain obscure. In addition to RBP-JΚ, the intra-cellular domain of Notch also interacts with other proteins in the cytoplasm and nucleus, giving rise to the possibility of a alternate, RBP-JΚ independent Notch pathways. However, the contribution of such RBP-JΚ independent, “non-canonical” Notch signaling in regulating peripheral T-cell responses is unknown. In this report we specifically demonstrate the requirement of Notch1 for regulating signal strength and signaling events distal to the T-cell receptor in peripheral CD4+ T cells. By using mice with a conditional deletion in Notch1 or RBP-JΚ, we show that Notch1 regulates activation and proliferation of CD4+ T cells independently of RBP-JΚ. Furthermore, differentiation to TH1 and iTreg lineages although Notch dependent, is RBP-JΚ independent. Our striking observations demonstrate that many of the cell intrinsic functions of Notch occur independently of RBP-JΚ.. Such non-canonical regulation of these processes likely occurs through NF-ΚB. This reveals a previously unknown, novel role of non-canonical Notch signaling in regulating peripheral T-cell responses.

3 June 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JRJustine E. Roderick
Justine E. Roderick
GGGabriela Gonzalez-Perez
Gabriela Gonzalez-Perez
CKChristina Arieta Kuksin
Christina Arieta Kuksin
ADAnushka Dongre
Anushka Dongre
EREmily R. Roberts
Emily R. Roberts
LMLisa M. M Minter
Lisa M. M Minter
Severe aplastic anemia (AA) is a bone marrow (BM) failure (BMF) disease frequently caused by aberrant immune destruction of blood progenitors. Although a Th1-mediated pathology is well described for AA, molecular mechanisms driving disease progression remain ill defined. The NOTCH signaling pathway mediates Th1 cell differentiation in the presence of polarizing cytokines, an action requiring enzymatic processing of NOTCH receptors by γ-secretase. Using a mouse model of AA, we demonstrate that expression of both intracellular NOTCH1IC and T-BET, a key transcription factor regulating Th1 cell differentiation, was increased in spleen and BM-infiltrating T cells during active disease. Conditionally deleting Notch1 or administering γ-secretase inhibitors (GSIs) in vivo attenuated disease and rescued mice from lethal BMF. In peripheral T cells from patients with untreated AA, NOTCH1IC was significantly elevated and bound to the TBX21 promoter, showing NOTCH1 directly regulates the gene encoding T-BET. Treating patient cells with GSIs in vitro lowered NOTCH1IC levels, decreased NOTCH1 detectable at the TBX21 promoter, and decreased T-BET expression, indicating that NOTCH1 signaling is responsive to GSIs during active disease. Collectively, these results identify NOTCH signaling as a primary driver of Th1-mediated pathogenesis in AA and may represent a novel target for therapeutic intervention.

26 March 2015 in Blood
Verified
Journal Article
Open access
PDF file
CKChristina Arieta Kuksin
Christina Arieta Kuksin
GGGabriela Gonzalez-Perez
Gabriela Gonzalez-Perez
LMLisa M. M Minter
Lisa M. M Minter
Key Points: NF-κB differentially regulates CXCR4 expression on naïve and pathogenic CD8+ T cells. CXCR4 expression on pathogenic T cells facilitates their trafficking to the BM in a mouse model of AA.

1 March 2019 in Stem Cell Research
Verified
Journal Article
Open access
EOE. Ilker Ozay
E. Ilker Ozay
JVJyothi Vijayaraghavan
Jyothi Vijayaraghavan
GGGabriela Gonzalez-Perez
Gabriela Gonzalez-Perez
SSSudarvili Shanthalingam
Sudarvili Shanthalingam
HSHeather L. Sherman
Heather L. Sherman
LMLisa M. M Minter
Lisa M. M Minter
The immune-mediated tissue destruction of graft-vs-host disease (GvHD) remains a major barrier to greater use of hematopoietic stem cell transplantation (HSCT). Mesenchymal stem cells (MSCs) have intrinsic immunosuppressive qualities and are being actively investigated as a therapeutic strategy for treating GvHD. We characterized Cymerus™ MSCs, which are derived from adult, induced pluripotent stem cells (iPSCs), and show they display surface markers and tri-lineage differentiation consistent with MSCs isolated from bone marrow (BM). Administering iPSC-MSCs altered phosphorylation and cellular localization of the T cell-specific kinase, Protein Kinase C theta (PKCθ), attenuated disease severity, and prolonged survival in a humanized mouse model of GvHD. Finally, we evaluated a constellation of pro-inflammatory molecules on circulating PBMCs that correlated closely with disease progression and which may serve as biomarkers to monitor therapeutic response. Altogether, our data suggest Cymerus iPSC-MSCs offer the potential for an off-the-shelf, cell-based therapy to treat GvHD.

26 May 2014 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HSHyun Mu Shin
Hyun Mu Shin
MTMulualem E. Tilahun
Mulualem E. Tilahun
OCOk Hyun Cho
Ok Hyun Cho
KCKarthik Chandiran
Karthik Chandiran
CKChristina Arieta Kuksin
Christina Arieta Kuksin
LMLisa M. M Minter
Lisa M. M Minter
T cell stimulation requires the input and integration of external signals. Signaling through the T cell receptor (TCR) is known to induce formation of the membrane-tethered CBM complex, comprising CARMA1, BCL10, and MALT1, which is required for TCR-mediated NF-κB activation. TCR signaling has been shown to activate NOTCH proteins, transmembrane receptors also implicated in NF-κB activation. However, the link between TCR-mediated NOTCH signaling and early events leading to induction of NF-κB activity remains unclear. In this report, we demonstrate a novel cytosolic function for NOTCH1 and show that it is essential to CBM complex formation. Using a model of skin allograft rejection, we show in vivo that NOTCH1 acts in the same functional pathway as PKCθ, a T cell-specific kinase important for CBM assembly and classical NF-κB activation. We further demonstrate in vitro NOTCH1 associates physically with PKCθ and CARMA1 in the cytosol. Unexpectedly, when NOTCH1 expression was abrogated using RNAi approaches, interactions between CARMA1, BCL10, and MALT1 were lost. This failure in CBM assembly reduced inhibitor of kappa B alpha phosphorylation and diminished NF-κB–DNA binding. Finally, using a luciferase gene reporter assay, we show the intracellular domain of NOTCH1 can initiate robust NF-κB activity in stimulated T cells, even when NOTCH1 is excluded from the nucleus through modifications that restrict it to the cytoplasm or hold it tethered to the membrane. Collectively, these observations provide evidence that NOTCH1 may facilitate early events during T cell activation by nucleating the CBM complex and initiating NF-κB signaling.